Cheng Cui is a Senior Translational Regulatory Affairs Director at AstraZeneca, where they have been employed since 2022. They previously held the position of GRA Dx Digital Director at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2020 to 2022. Cheng had a diverse research background, serving as a Postdoctoral Fellow at the University of Kansas Medical Center from 2005 to 2007 and as a Research Fellow at the National Institutes of Health from 2008 to 2009. Their experience includes working as a Senior Scientific Reviewer at the FDA from 2019 to 2020 and as a Research Associate & System Programmer IV at UPMC from 2010 to 2014. Cheng earned an M.S. in Physics from the University of Notre Dame and a Ph.D. in Biophysics from Indiana University Bloomington.
This person is not in any teams
This person is not in any offices